Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Understanding why some people benefit from cognitive behavioral therapy

Official title: Contributions of Self-Focused Attention to Early Warning Indicators of Cognitive Behavioral Therapy Non-Response

Run by University of Washington · NCT06678295 · Data updated 2026-11-12

This study is trying to find out why some people with social anxiety and body dysmorphic disorder get better from cognitive behavioral therapy while others don’t, by looking at their brain scans and other information during treatment.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment160 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedOctober 15, 2024
Main results expectedSeptember 30, 2028
Study endsSeptember 30, 2028
Registry record updatedFebruary 17, 2026
Trial IDNCT06678295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are treatment-seeking adults aged 18-45 with a primary diagnosis of social anxiety disorder or body dysmorphic disorder.

Probably not a fit

Patients with a history of psychiatric disorders or those who do not meet the inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to explore the individual factors that contribute to the success of cognitive behavioral therapy (CBT) in treating social anxiety disorder and body dysmorphic disorder. By analyzing neural, neurocognitive, clinical, and self-report data, the study seeks to identify why some individuals respond positively to CBT while others do not. Participants will undergo 12 sessions of CBT along with neuroimaging scans before, during, and after treatment. The study will include both clinical participants with the target disorders and healthy control participants for comparison.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for individuals with social anxiety disorder and body dysmorphic disorder.

How similar studies have gone: Other studies have shown promise in understanding individual responses to CBT, but this specific approach focusing on self-focused attention biomarkers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Clinical sample (N=110):

1. Men and women, age 18-45
2. Treatment-seeking individuals who meet criteria for a primary DSM-5 diagnosis of primary social anxiety disorder (SAD) or body dysmorphic disorder (BDD) based on the SCID-5-RV
3. Fluent in English and willing to provide informed consent.

Control sample (N=50):

1. Men and women, age 18-45
2. No current or lifetime history of psychiatric disorders, as assessed using the SCID-5-RV
3. Meet criteria for low levels of anxiety (GAD-7 score of \<8) and depression (PHQ-9 score \<10)
4. Fluent in English and willing to provide informed consent

Exclusion Criteria:

All groups:

1. Score \< 80 based on WRAT5 Word Reading Subtest
2. fMRI contraindications (e.g., electronic medical devices such as pacemakers, implanted defibrillators, etc.; metal implants not approved for MRI; pregnancy; claustrophobia)

2\. Active suicidal or homicidal ideation, or any features requiring a higher level of care 3. Lifetime history of manic or hypomanic episode, psychotic symptoms, traumatic brain injury, neurological disorder, pervasive developmental disorder, or attention deficit-hyperactivity disorder; active alcohol or substance use disorder in the past 6 months 4. Current use of psychotropic medications, except antidepressants taken at a stable dose for 3 months prior to study baseline 5. Previous CBT non-responder or current CBT

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Angela Fang, PhD — University of Washington
  • Study coordinator: Angela Fang, PhD
  • Email: angfang@uw.edu
  • Phone: (206) 616-5783

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.